Introduction {#s1}
============

Eukaryotic genomic DNA is folded with histones and non-histone proteins in the form of chromatin, which regulates every aspect of DNA metabolism, including transcription, replication, recombination, and DNA damage repair. Chromatin is classified into euchromatin, which is gene rich and actively transcribed, and heterochromatin, which is gene poor and highly compacted ([@bib11]). Heterochromatin preferentially forms at repetitive DNA elements in order to limit transcription and recombination at these regions to maintain genome integrity. It also forms at developmentally regulated genes to regulate their expression in response to developmental cues and external stimuli. Heterochromatin tends to spread into neighboring regions, leading to the inactivation of genes in a sequence-independent manner ([@bib46]; [@bib50]). Therefore, the sites of heterochromatin formation and extent of heterochromatin spreading need to be tightly controlled to prevent improper gene silencing, and misregulation of heterochromatin assembly has been linked to many human diseases, especially various types of cancers ([@bib9]).

Heterochromatic regions generally have distinct chromatin signatures such as histones that are hypoacetylated and methylated at histone H3 lysine 9 (H3K9me), and the enrichment of HP1 family proteins ([@bib38]; [@bib4]; [@bib27]; [@bib34]). Formation of heterochromatin requires the concerted actions of a diverse group of histone-modifying proteins, such as H3K9 methyltransferases and histone deacetylases (HDACs), and is divided into three distinct steps: establishment, spreading, and maintenance ([@bib12]; [@bib41]). Heterochromatin is established at nucleation centers through the targeting of histone-modifying activities by transcription factors or non-coding RNAs ([@bib7]). Subsequently, heterochromatin spreads into neighboring regions, mostly via a network of interactions among chromatin proteins, resulting in the formation of large heterochromatin domains independent of the underlying DNA sequences ([@bib46]; [@bib7]). Once these domains are formed, they can maintain themselves also through interactions among chromatin proteins even in the absence of the initiation signal ([@bib32]; [@bib37]).

The formation of heterochromatin has been extensively studied in fission yeast, which uses highly conserved histone-modifying enzymes and chromatin proteins for heterochromatin assembly, such as the SUV39 family histone H3K9 methyltransferase Clr4, the HP1 homologue Swi6, and HDACs Sir2 and Clr3 ([@bib11]). There are four types of heterochromatin identified in fission yeast: constitutive heterochromatin at repeat regions such as centromeres, telomeres, and the silent mating-type region ([@bib11]); facultative heterochromatin islands at a subset of meiotic genes ([@bib17]; [@bib58]; [@bib47]; [@bib8]); HOODs (heterochromatin domains) at sexual differentiation genes and retrotransposons in response to the misregulation of the exosome ([@bib55]); and transient heterochromatin at convergent genes ([@bib13]). These locations use distinct pathways to recruit histone-modifying activities to form heterochromatin.

The establishment of constitutive heterochromatin at repetitive DNA elements requires the RNA interference (RNAi) pathway, a phenomenon also vastly conserved in eukaryotes ([@bib31]; [@bib29]; [@bib6]). The DNA repeats are transcribed and the transcripts are processed by the RNAi machinery into small interfering RNAs (siRNAs), which target the Clr4 complex (CLRC, consisting of Clr4, Cul4, Rik1, Raf1, and Raf2) to repeat regions to initiate H3K9me. In addition, DNA binding factors, such as telomeric shelterin and stress-activated ATF/CREB family proteins Atf1/Pcr1, also directly recruit histone-modifying activities to establish constitutive heterochromatin at telomeres and the silent mating-type region, respectively ([@bib22]; [@bib25]; [@bib24]; [@bib45]). The formation of facultative heterochromatin islands at meiotic genes requires RNA binding protein Mmi1, Zinc finger protein Red1, and the exosome ([@bib17]; [@bib58]; [@bib47]; [@bib8]). Mmi1 binds to RNA transcripts containing DSR (determinant of selective removal) sequences and recruits the RNA-induced transcriptional silencing (RITS) complex and the Red1-Mtl1 complex, which directly interacts with Clr4 complex, to initiate H3K9me at meiotic genes ([@bib15]; [@bib58]; [@bib28]; [@bib8]). HOODs are formed at sexual differentiation genes and retrotransposons in response to exosome malfunction or changes in environmental conditions and requires RNAi, polyA polymerase Pla1, and PolyA binding protein Pab2 ([@bib28]; [@bib55]). Convergent genes generate overlapping transcripts during the G1 phase of the cell cycle, which induce the formation of transient heterochromatin through the RNAi pathway ([@bib13]).

The spreading of heterochromatin requires Swi6 and the chromodomain of Clr4, both of which bind to H3K9me and position Clr4 to methylate neighboring nucleosomes ([@bib14]; [@bib56]; [@bib1]). The reiteration of H3K9 methylation and recruitment of Clr4 by H3K9me, either directly through the chromodomain or indirectly through Swi6, results in the 'inch-worm'-like spreading of heterochromatin from nucleation centers into large chromosome domains ([@bib46]; [@bib50]). Some heterochromatin regions are flanked by DNA sequences termed boundary elements, which block heterochromatin spreading ([@bib50]). In other cases, heterochromatin borders are determined by the local balance of heterochromatin and euchromatin proteins, which tends to differ between cells. Therefore, precise regulation of heterochromatin spreading is essential to maintain stable gene expression profiles.

One of the best-known negative regulators of heterochromatin spreading is Epe1 as *epe1∆* results in heterochromatin spreading beyond its normal boundaries as well as ectopic heterochromatin formation ([@bib57]; [@bib48]; [@bib58]; [@bib37]). Loss of Epe1 also bypasses RNAi for pericentric heterochromatin assembly by strengthening heterochromatin spreading ([@bib48]). Epe1 contains a JmjC domain, which is frequently associated with histone demethylase activity. Although no demethylase activity has been detected for Epe1 ([@bib49]), genetic evidence is consistent with Epe1 being a H3K9 demethylase and conserved catalytic residues are essential for Epe1 function ([@bib48]; [@bib37]).

The Mst2 complex is similar in composition to budding yeast NuA3 and mammalian HBO1/MOZ/MORF complexes ([@bib53]). It is a highly specific histone H3K14 acetyltransferase that cooperates with Gcn5 to regulate global H3K14 acetylation levels ([@bib36]; [@bib53]). The formation of heterochromatin is negatively correlated with H3K14 acetylation ([@bib44]; [@bib33]), and *mst2∆* bypasses the requirement of the RNAi pathway for pericentric heterochromatin assembly through modulating H3K14ac levels at heterochromatin ([@bib39]). Moreover, *mst2∆* strengthens silencing at telomeres ([@bib10]). These results suggest that Mst2 complex functions to antagonize heterochromatic silencing, although the mechanism by which it affects heterochromatin assembly is unknown. The ability to bypass RNAi requires ablating the enzymatic activity of the Mst2 complex ([@bib39]). It was proposed that Mst2-mediated H3K14 acetylation regulates histone turnover at heterochromatin regions and the loss of such activity preserves parental histone modifications to promote heterochromatin maintenance ([@bib39]), although the ability of Mst2 to regulate histone turnover has not been directly tested.

In this study, we show that Mst2 regulates histone turnover at heterochromatin regions and that loss of Mst2 results in heterochromatin spreading at telomeres and heterochromatin islands where boundaries are absent. We also found that *mst2∆ epe1∆* cells are initially very sick due to heterochromatin spreading-mediated inactivation of essential genes, suggesting that Mst2 and Epe1 function redundantly in regulating heterochromatin spreading. Interestingly, these cells quickly recover by forming ectopic heterochromatin at the *clr4*^*+*^ locus to mitigate the negative effects of heterochromatin. Disrupting heterochromatin assembly at the *clr4*^*+*^ locus results in ectopic heterochromatin formation at the *rik1*^*+*^ locus, which encodes another subunit of the Clr4 complex required for H3K9me. These results demonstrate that promiscuous heterochromatin assembly generates epigenetic mutations that provide fast adaptions to heterochromatin stress.

Results {#s2}
=======

Mst2 regulates histone turnover at heterochromatin {#s2-1}
--------------------------------------------------

To directly examine the role of the Mst2 complex in regulating histone turnover, we generated a Flag-tagged version of histone H3 driven by the *urg1* promoter at the endogenous *urg1*^*+*^ locus, which can be quickly induced by the addition of uracil into the growth medium at levels far below the endogenous histone H3 ([@bib54]) ([Figure 1A](#fig1){ref-type="fig"}). To prevent replication-dependent histone incorporation, we blocked the cell cycle with hydroxyl urea (HU) before induction of H3-Flag expression ([Figure 1B](#fig1){ref-type="fig"}). We found that pericentric *dh* repeat was associated with lower amounts of H3-Flag in wild-type cells compared with RNAi mutant *dcr1∆* ([Figure 1C](#fig1){ref-type="fig"}), suggesting that histone turnover rates increase when heterochromatin is compromised. In addition, the incorporation of H3-Flag was reduced in *epe1∆ dcr1∆* cells, as observed previously ([Figure 1C](#fig1){ref-type="fig"}) ([@bib3]). In *mst2∆ dcr1∆* cells, H3-Flag incorporation was reduced to wild-type levels ([Figure 1C](#fig1){ref-type="fig"}), suggesting that the Mst2 complex indeed regulates histone turnover at heterochromatin.10.7554/eLife.06179.003Figure 1.Mst2 counteracts heterochromatin assembly.(**A**) Western blot analysis of H3-Flag levels. Samples were taken at indicated times after the addition of uracil, and Western blot analyses were performed with Flag and H3 antibodies. (**B**) Schematic diagram of the histone turnover assay. (**C**) Enrichment of H3-Flag at pericentric *dh* sequence as an indicator of histone turnover rates. The values are normalized to a region within the silent mating-type locus with background histone turnover ([@bib3]). Error bars represent standard deviation of three experiments. (**D**) ChIP--chip analyses of H3K9me2 levels across the genome. (**E**) ChIP--chip data of H3K9me2 levels around the telomere IL, centromere I, the silent mating-type region, and the *mei4*^*+*^ locus. (**F**) Mst2 is not required for boundary function at *IRC1R*. Serial dilution analysis were performed to measure the expression of *IRC1R::ura4*^*+*^ reporter.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.003](10.7554/eLife.06179.003)10.7554/eLife.06179.004Figure 1---figure supplement 1.ChIP--chip data of H3K9me2 levels around centromere II, centromere III, telomere 1R, telomere 2L, and telomere 2R.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.004](10.7554/eLife.06179.004)

To further examine the role of the Mst2 complex in regulating heterochromatin assembly, we performed Chromatin Immunoprecipitation coupled with DNA microarray (ChIP--chip) analyses of H3K9me2 levels across the fission yeast genome. In wild-type cells, H3K9me2 was mainly present at centromeres, telomeres, and the silent mating-type region ([Figure 1D](#fig1){ref-type="fig"}). There were also a few heterochromatic islands with low levels of H3K9me2 ([Figure 1D](#fig1){ref-type="fig"}). Although less heterochromatic islands were identified compared to a recent study ([@bib58]), our results are consistent with that of an earlier one ([@bib5]). The discrepancies might be caused by the use of batches of antibody with different sensitivity or different data processing methods. In *mst2∆* cells, constitutive heterochromatin domains at centromeres and the silent mating-type region were in good agreement with wild-type cells, but telomeric heterochromatin showed significant spreading into chromosome arms ([Figure 1D,E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), consistent with previous findings that *mst2∆* strengthens silencing at telomeres ([@bib10]). Interestingly, there are a number of additional small H3K9me2 peaks scattered across the genome, most of which are also present in *epe1∆* cells ([Figure 1D,E](#fig1){ref-type="fig"}, and [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) ([@bib58]). Therefore, Mst2 also prevents ectopic heterochromatin assembly, similar to Epe1. We observed only minor heterochromatin spreading in telomeric regions in *epe1∆* cells compared with a previous study ([@bib58]), which might be due to the presence of two epigenetically stable subpopulations of cells with different effects on heterochromatin assembly ([@bib48]).

The difference between pericentric regions, telomeres, and heterochromatin islands is the presence of well-defined boundary elements at pericentric regions that block heterochromatin spreading ([@bib50]). We found that *mst2∆* has no effect on boundary activity of an inverted repeat at the pericentric region, *IRC1R*, which requires Epe1 and the double bromodomain protein Bdf2 for function ([Figure 1F](#fig1){ref-type="fig"}) ([@bib52]), suggesting that Mst2 regulates heterochromatin spreading only in the absence of boundaries.

Misregulation of heterochromatin affects the fitness of *mst2Δ epe1Δ* cells {#s2-2}
---------------------------------------------------------------------------

Since *mst2∆* and *epe1∆* have similar phenotypes in heterochromatin assembly and each bypasses the RNAi pathway for pericentric heterochromatin functions ([@bib48]; [@bib39]), we generated *mst2∆ epe1∆* cells to examine their epistatic relationship. All freshly generated *mst2∆ epe1∆* cells formed very small colonies, suggesting a strong negative genetic interaction between these two mutants ([Figure 2A](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), consistent with high throughput epistasis mapping ([@bib40]; [@bib42]). Moreover, abolishing the enzymatic activity of Mst2 (*mst2-E274Q* or *nto1∆*) or Epe1 (*epe1-H374A* and *epe1-Y307A*) resulted in similar sickness ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that the enzymatic activities of Mst2 and Epe1 have redundant functions. Double mutant of *mst2∆ bdf2∆* had no defects in growth ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that the boundary activity of Epe1 is not involved in genetic interaction with Mst2.10.7554/eLife.06179.005Figure 2.A suppressor mutation confers normal growth of *mst2∆ epe1∆* cells.(**A**, **D**, **E**, **H**) Tetrad dissection analysis of the indicated genetic crosses. Pictures are examples of colonies derived from the same tetrad containing all individual genotypes, after one replication for a total of 6 days growth. (**B**) Serial dilution analysis of indicated strains. Cells were grown in rich medium overnight before dilution analyses were performed. (**C**) The growth curve of indicated strains. (**F**) Workflow to introduce *mst2∆* and *epe1∆* into the deletion library. (**G**) Left, a representative image of colony growth was shown. Middle, colonies were assigned scores between 0 and 3, as indicated. Right, list of identified heterochromatin mutants that confer fast growth.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.005](10.7554/eLife.06179.005)10.7554/eLife.06179.006Figure 2---figure supplement 1.Tetrad dissection analysis of the indicated genetic crosses.(**A**) Genetic cross between *mst2∆* and *epe1∆* to show the frequency of *mst2∆ epe1∆* colonies (red boxes). Each column is a tetrad. Genotypes are indicated on the right. WT, wild type; m, *mst2∆*; e, *epe1∆*; me, *mst∆ epe1∆*; ?, genotype can not be assigned. Red letters indicate no colony growth detected. (**B**) Representative examples of colonies derived from the same tetrad containing all individual genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.006](10.7554/eLife.06179.006)10.7554/eLife.06179.007Figure 2---figure supplement 2.Tetrad dissection analysis of indicated genetic crosses.Pictures are representative examples of colonies derived from the same tetrad containing all individual genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.007](10.7554/eLife.06179.007)

Interestingly, cells from the small *mst2∆ epe1∆* colonies grew comparably to wild-type cells ([Figure 2B,C](#fig2){ref-type="fig"}), suggesting that the accumulation of either a genetic or more intriguingly, an epigenetic suppressor leads to quick and persistent production of normally growing *mst2∆ epe1∆* cells. We crossed independent clones of recovered *mst2∆ epe1∆* cells (*mst2∆ epe1∆\**, which denotes the presence of a suppressor) and found that all resulting progenies grew normally from the beginning ([Figure 2D](#fig2){ref-type="fig"}). Moreover, when we crossed *mst2∆ epe1∆\** cells with wild-type cells, half of the resulting *mst2∆ epe1∆* colonies were small and the other half were normal ([Figure 2E](#fig2){ref-type="fig"}), suggesting that changes associated with a single genomic locus was responsible for the recovery of these cells and also ruling out the possibility that the initial growth defects were the result of these cells going through meiosis.

To identify the suppressor, we performed two successive rounds of crosses to introduce *mst2∆* and *epe1∆* into the fission yeast deletion library and measured the initial growth of triple mutants before accumulation of a suppressor ([Figure 2F](#fig2){ref-type="fig"}). Interestingly, a number of heterochromatin assembly mutants allowed robust growth of *mst2∆ epe1∆* cells. Such mutants included deletions of components of the CLRC histone H3K9 methyltransferase complex (*clr4∆*, *raf1∆*, and *raf2∆*), an HP1 protein (*swi6∆*), and histone deacetylases (*sir2∆* and *clr3∆*) ([Figure 2G](#fig2){ref-type="fig"} and [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). In contrast, none of the RNAi factors were identified in our screen. Individual crosses also confirmed that heterochromatin mutants conferred normal growth to *mst2∆ epe1∆* cells ([Figure 2H](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Such data suggest that the effect of *mst2∆ epe1∆* on cell growth is possibly the result of misregulation of heterochromatin.

Increased heterochromatin spreading is responsible for the initial growth defects of *mst2Δ epe1Δ* cells {#s2-3}
--------------------------------------------------------------------------------------------------------

To determine whether there are any global changes in heterochromatin organization, we decided to perform ChIP--chip analysis of H3K9me2 levels across the genome in *mst2∆ epe1∆* cells. However, the quick generation of epigenetic suppressors in *mst2∆ epe1∆\** cells prevented us from directly testing the reason for the initial growth defects. Because H3K9me functions upstream of Swi6 localization and the silencing function of H3K9me requires Swi6, we reasoned that examining H3K9me2 levels in *mst2∆ epe1∆ swi6∆* cells might show the misregulation of heterochromatin assembly that resembles early stages *mst2∆ epe1∆* cells. Indeed, in *mst2∆ epe1∆ swi6∆* cells, the H3K9me2 domains at constitutive heterochromatin regions such as centromeres showed significant expansion, even when boundary elements are present ([Figure 3A,B](#fig3){ref-type="fig"}). In addition, many additional peaks of H3K9me2 were detected across the genome, at levels comparable to constitutive heterochromatin domains ([Figure 3A,B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, and [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Most, but not all, of these additional sites correspond to previously described heterochromatin islands. Compared to wild-type, *mst2∆*, or *epe1∆* cells, these heterochromatic islands were also greatly expanded ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Given that Swi6 also contributes to heterochromatin spreading ([@bib14]; [@bib1]), heterochromatin probably spreads over even longer distances when Swi6 is present. Interestingly, essential genes reside within or near some of the expanded H3K9me2 domains ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), suggesting that misregulation of heterochromatin spreading inactivates essential genes and causes the initial sickness of *mst2∆ epe1∆* cells.10.7554/eLife.06179.008Figure 3.Increased heterochromatin spreading in *mst2∆ epe1∆* cells leads to growth defects.(**A**) ChIP--chip analyses of H3K9me2 levels across the genome. (**B**) ChIP--chip data of H3K9me2 levels at centromere I, *mei4*^*+*^, *mcp7*^*+*^, and *clr4*^*+*^ locus. (**C**) Tetrad dissection analysis of the indicated genetic cross. (**D**) ChIP-qPCR analysis of H3K9me2 levels at indicated locations, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.008](10.7554/eLife.06179.008)10.7554/eLife.06179.009Figure 3---figure supplement 1.ChIP--chip data of H3K9me2 levels at heterochromatin islands.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.009](10.7554/eLife.06179.009)

If heterochromatin spreading is the cause of the initial growth defects of *mst2∆ epe1∆* cells, we expect that mutations blocking heterochromatin spreading will abolish such an effect. The spreading of heterochromatin requires Swi6 as well as the chromodomain of Clr4, which binds to pre-existing H3K9me to allow the modification of adjacent nucleosomes ([@bib14]; [@bib56]; [@bib1]). Our data that *mst2∆ epe1∆ swi6∆* allows normal growth ([Figure 2H](#fig2){ref-type="fig"}) is consistent with such a hypothesis. However, Swi6 is required for heterochromatin spreading as well as heterochromatin-mediated silencing, making it difficult to definitively assess the contribution of heterochromatin spreading in this process. We therefore tested a mutation within the Clr4 chromodomain, W31G, which affects the binding of Clr4 to H3K9me to block heterochromatin spreading ([@bib56]). Indeed, *mst2∆ epe1∆ clr4-W31G* cells showed no initial growth defects ([Figure 3C](#fig3){ref-type="fig"}) and heterochromatin expansion is prevented as indicated by ChIP analysis of H3K9me2 levels outside of centromere I boundary and at the *mei4*^*+*^ locus ([Figure 3D](#fig3){ref-type="fig"}).

Ectopic heterochromatin at the *clr4*^*+*^ locus promotes adaption of *mst2Δ epe1Δ* cells {#s2-4}
-----------------------------------------------------------------------------------------

ChIP--chip analysis also showed that the patterns and levels of H3K9me2 in *mst2∆ epe1∆\** cells were more similar to those in wild-type cells with high levels of H3K9me2 at constitutive heterochromatic regions and low levels of H3K9me2 at heterochromatic islands, and much less heterochromatin spreading compared with *mst2∆ epe1∆ swi6∆* cells ([Figure 3A,B](#fig3){ref-type="fig"}). Most significantly, H3K9me2 was enriched at a 5 kilobase region covering *clr4*^*+*^ and an adjacent gene *meu6*^*+*^, at levels comparable to constitutive heterochromatin regions in independent clones tested ([Figures 3A,B, and 4A](#fig3 fig4){ref-type="fig"}, and data not shown). Consistent with the fact that H3K9me is associated with gene silencing, both *clr4*^*+*^ mRNA and Clr4 protein levels were reduced in *mst2∆ epe1∆\** cells ([Figure 4B,C](#fig4){ref-type="fig"}).10.7554/eLife.06179.010Figure 4.Inheritance of ectopic heterochromatin at the *meu6-clr4* locus.(**A**, **E**) ChIP-qPCR analysis of H3K9me2 levels at the *clr4*^*+*^ coding region, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments. (**B**, **F**) qRT-PCR analysis of *clr4*^*+*^ mRNA levels, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments. (**C**) Western blot analyses of Flag-Clr4 and Tubulin protein levels. (**D**) Tetrad dissection analysis of indicated genetic crosses. (**G**) Serial dilution analysis to measure the expression of *otr::ura4*^*+*^ reporter.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.010](10.7554/eLife.06179.010)

To test if the epigenetically silenced *clr4*^*+*^ locus is the suppressor of *mst2∆ epe1∆\** cells, we crossed *mst2∆ epe1∆\** (containing a methylated *clr4*^*+*^ locus) with *Flag-clr4*^*+*^ cells (containing an unmethylated *Flag-clr4*^*+*^ locus). We found that the resulting *mst2∆ epe1∆ clr4*^*+*^ daughters (inheriting the methylated *clr4*^*+*^ locus) grew normally, whereas the *mst2∆ epe1∆ Flag-clr4*^*+*^ daughters (inheriting the unmethylated *Flag-clr4*^*+*^ locus) were sick ([Figure 4D](#fig4){ref-type="fig"}). Moreover, ChIP analysis showed that the *mst2∆ epe1∆ clr4*^*+*^ progeny also inherited H3K9me2 associated with this locus ([Figure 4E](#fig4){ref-type="fig"}), and *clr4*^*+*^ mRNA levels were low ([Figure 4F](#fig4){ref-type="fig"}). Therefore, the inheritance of a silenced *clr4*^*+*^ locus allows cells to avoid the negative effects on cell growth imposed by *mst2∆ epe1∆*. In contrast, wild-type cells inheriting the methylated *clr4*^*+*^ locus lost H3K9me2, *clr4*^*+*^ mRNA levels were significantly restored, and these cells exhibited no defects in the silencing of a pericentric *otr::ura4*^*+*^ reporter gene ([Figure 4E,F,G](#fig4){ref-type="fig"}). These results suggest that the silencing of *clr4*^*+*^ is epigenetic and not due to changes in DNA sequence. They also suggest that the continued absence of Mst2 and Epe1 is required to maintain H3K9me2 at the *clr4*^*+*^ locus.

Sequences 3′ to *clr4*^*+*^ is required for heterochromatin assembly at the *clr4*^*+*^ locus in *mst2Δ epe1Δ* cells {#s2-5}
--------------------------------------------------------------------------------------------------------------------

We then examined whether any of the known heterochromatin assembly pathways are required for heterochromatin assembly at the *clr4*^*+*^ locus in *mst2∆ epe1∆* cells. We found that *mst2∆ epe1∆ dcr1∆* cells also quickly recovered and H3K9me2 levels were similar at the *clr4*^*+*^ locus in *mst2∆ epe1∆\** and *mst2∆ epe1∆ dcr1∆\** cells, suggesting that RNAi is not required for heterochromatin assembly at *clr4*^*+*^, even though *clr4*^*+*^ is in a convergent orientation with *meu6*^*+*^ ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). In addition, H3K9me2 levels persisted in *mst2∆ epe1∆ mmi1∆\** and *mst2∆ epe1∆ pab2∆\** cells ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), suggesting that heterochromatin assembly is not through Mmi1-mediated facultative heterochromatin assembly pathway or Pab2-mediated assembly of HOOD, even though *meu6*^*+*^ is a meiotic gene. Therefore, heterochromatin assembly at *clr4*^*+*^ differs from known heterochromatin assembly pathways. Due to the severe growth defects associated with *red1∆* or *rrp6∆*, we were unable to generate triple mutant strains with *mst2∆ epe1∆* and whether these factors are involved in H3K9me2 at the *clr4*^*+*^ locus in *mst2∆ epe1∆* cells is unknown.

The domain of H3K9me2 in *mst2∆ epe1∆\** cells includes *clr4*^*+*^ and *meu6*^*+*^, with its center within *meu6*^*+*^ coding region. Interestingly, RNA sequencing analysis showed that *meu6*^*+*^ is not expressed in vegetative growing cells and *clr4*^*+*^ transcript runs through the entire *meu6*^*+*^ gene ([Figure 5A](#fig5){ref-type="fig"}) ([@bib51]). We therefore replaced the entire *meu6*^*+*^ open reading frame with a *kanMX6* cassette, in the same transcription orientation as *meu6*^*+*^ ([Figure 5B](#fig5){ref-type="fig"}). Given that *meu6*^*+*^ is right next to *clr4*^*+*^, we first examined whether this manipulation affects Clr4 function. We found that *meu6∆::kanMX6* has no silencing defects at *otr::ura4*^*+*^, and *clr4*^*+*^ mRNA and Clr4 protein levels were similar to those of wild-type cells ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). ChIP analysis showed that H3K9me2 was abolished at the *clr4*^*+*^ locus in *mst2∆ epe1∆ meu6∆\** cells ([Figure 5C](#fig5){ref-type="fig"}), and *clr4*^*+*^ mRNA and Clr4 protein levels were similar to wild-type cells ([Figure 5D,E](#fig5){ref-type="fig"}). We also generated a *meu6-Flag::KanMX6* strain, which preserves the coding sequence of *meu6*^*+*^, and found that H3K9me2 levels at the *clr4*^*+*^ locus were also abolished in *mst2∆ epe1∆ meu6-Flag::KanMX6* cells ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), suggesting that the *meu6*^*+*^ coding sequence is not responsible for heterochromatin assembly at this locus, but rather the insertion of the *KanMX6* cassette disrupts a heterochromatin initiation signal. Given that the *clr4*^*+*^ transcript has a long 3′-UTR and that both *meu6∆::KanMX6* and *meu6-Flag::KanMX6* alter the 3′-UTR, heterochromatin assembly at the *clr4*^*+*^ locus likely requires the intact 3′-UTR of *clr4*^*+*^.10.7554/eLife.06179.011Figure 5.Blocking heterochromatin formation at the *clr4*^*+*^ locus in *mst2∆ epe1∆* cells results in ectopic heterochromatin assembly at the *rik1*^*+*^ locus.(**A**) RNA sequencing data of the *meu6-clr4* region. (**B**) Schematic diagram of the *meu6∆::kanMX6* construct. (**C**, **I**) ChIP-qPCR analysis of H3K9me2 levels at the *clr4*^*+*^ or *rik1*^*+*^ coding region, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments. (**D**, **J**) qRT-PCR analysis of *clr4*^*+*^ or *rik1*^*+*^ mRNA levels, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments. (**E**) Western blot analyses of Flag-Clr4 protein levels. (**F**) The growth curve of indicated strains. (**G**) ChIP--chip analyses of H3K9me2 levels across the genome in recovered *mst2∆ epe1∆ meu6∆\** cells. (**H**) ChIP--chip data of H3K9me2 levels at *clr4*^*+*^ and *rik1*^*+*^ loci.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.011](10.7554/eLife.06179.011)10.7554/eLife.06179.012Figure 5---figure supplement 1.Dcr1, Mmi1 and Pab2 are not required for heterochromatin assembly at the *clr4^+^* locus in *mst2Δ epe1Δ*\* cells.(**A**) Serial dilution analysis of indicated strains. Cells were grown in rich medium overnight before dilution analyses were performed. (**B**) The growth curve of indicated strains. (**C**) ChIP-qPCR analysis of H3K9me2 levels at the *clr4*^*+*^ coding region, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.012](10.7554/eLife.06179.012)10.7554/eLife.06179.013Figure 5---figure supplement 2.*meu6∆* has no effect on *clr4^+^* expression under normal conditions.(**A**) Serial dilution analysis was performed to measure the expression of *otr::ura4*^*+*^. (**B**) qRT-PCR analysis of *clr4*^*+*^ mRNA levels, normalized against *act1*^*+*^ mRNA. Error bars represent standard deviation of three experiments. (**C**) Western blot analysis to measure Flag-Clr4 protein levels.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.013](10.7554/eLife.06179.013)10.7554/eLife.06179.014Figure 5---figure supplement 3.Meu6-Flag abolished H3K9me in *mst2∆ epe1∆* cells.(**A**) Schematic diagram of *meu6-Flag*. (**B**) ChIP-qPCR analysis of H3K9me2 levels at the *clr4*^*+*^ and *rik1^+^* coding region, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.014](10.7554/eLife.06179.014)

Disrupting ectopic heterochromatin assembly at the *clr4*^*+*^ locus results in ectopic heterochromatin assembly at the *rik1*^*+*^ locus {#s2-6}
-----------------------------------------------------------------------------------------------------------------------------------------

If the silenced *clr4*^*+*^ is the suppressor in *mst2∆ epe1∆\** cells, we expect that abolishing H3K9me2 at the *clr4*^*+*^ locus will result in the failure of *mst2∆ epe1∆* cells to recover. Interestingly, *mst2∆ epe1∆ meu6∆\** cells were able to recover to some extent although they grew at a slower rate compared to wild-type or *mst2∆ epe1∆\** cells ([Figure 5F](#fig5){ref-type="fig"}). To understand how *mst2∆ epe1∆ meu6∆\** cells recover without silencing of *clr4*^*+*^, we performed ChIP--chip analysis of H3K9me2 levels in *mst2∆ epe1∆ meu6∆\** cells ([Figure 5G](#fig5){ref-type="fig"}). The distribution of H3K9me2 is on the whole similar to that of *mst2∆ epe1∆\** cells, with two major exceptions. First, H3K9me2 was indeed abolished from the entire *meu6*^*+*^*-clr4*^*+*^ region ([Figure 5G,H](#fig5){ref-type="fig"}). Second, an additional peak of H3K9me2 appeared at a 7-kb region that includes two genes in convergent orientation: *rik1*^*+*^, which encodes a component of the Clr4 complex and is required for Clr4 function ([@bib34]; [@bib18]; [@bib19]; [@bib21]), and an uncharacterized gene *SPCC11E10.09c*^*+*^ ([Figure 5G,H,I](#fig5){ref-type="fig"}). As expected, *rik1*^*+*^ mRNA levels were significantly reduced in *mst2∆ epe1∆ meu6∆\** cells compared to wild-type or *mst2∆ epe1∆\** cells ([Figure 5J](#fig5){ref-type="fig"}). It is likely that the reduction of *rik1*^*+*^ expression allows *mst2∆ epe1∆ meu6∆\** cells to grow to some extent by decreasing global H3K9me and heterochromatin assembly. We suspect that *mst2∆ epe1∆ meu6∆\** cells recovered less well than *mst2∆ epe1∆\** cells because heterochromatin forms less efficiently at the *rik1*^*+*^ locus, which might explain why independent *mst2∆ epe1∆\** clones all preferentially silenced *clr4*^*+*^ (data not shown). Moreover, H3K9me2 was also enriched at the *rik1*^*+*^ locus in *mst2∆ epe1∆ meu6-Flag\** cells ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}), suggesting that the formation of heterochromatin at this locus is not random.

Mst2 and Epe1 are required to counteract the high activity of Clr4 {#s2-7}
------------------------------------------------------------------

It is interesting to note that the enzymatic activity of Clr4 is much higher than that of its mammalian counterparts ([@bib38]). Therefore, Mst2 and Epe1 are likely evolved to counteract such a hyperactive H3K9 methyltransferase. Clr4 has an arginine at residue 406, which corresponds to a histidine in its mammalian and *Drosophila* homologues ([Figure 6A](#fig6){ref-type="fig"}). Conversion of the histidine to arginine (H320R) makes mammalian SUV39H1 a hyperactive histone methyltransferase ([@bib38]). We generated a R406H mutation in Clr4 and found that this mutation resulted in a drastic reduction of Clr4 enzymatic activity in vitro ([Figure 6B](#fig6){ref-type="fig"}). When introduced into the endogenous *clr4*^*+*^ locus, *R406H* moderately affected silencing of a pericentric *otr::ura4*^*+*^ reporter, indicating that high activity of Clr4 is required for heterochromatin assembly in wild-type cells ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Interestingly, *mst2∆ epe1∆ clr4-R406H* had no initial growth defects ([Figure 6C](#fig6){ref-type="fig"}), no H3K9me2 at the *clr4*^*+*^ locus ([Figure 6D](#fig6){ref-type="fig"}), and *clr4*^*+*^ transcript levels were not affected ([Figure 6E](#fig6){ref-type="fig"}). Therefore, a less active Clr4 can also mitigate the effects of simultaneous loss of Mst2 and Epe1.10.7554/eLife.06179.015Figure 6.The high activity of Clr4 leads to growth defects of *mst2∆ epe1∆* cells.(**A**) Sequence alignment of part of Clr4 homologues. \* indicates R406 of Clr4. (**B**) In vitro histone methyltransferase assays were performed with recombinant GST-Clr4 or GST-Clr4-R406H together with a histone H3 (1--21) peptide. For the control reaction, no Clr4 was added. (**C**) Tetrad dissection analysis of the indicated genetic cross. (**D**) ChIP-qPCR analysis of H3K9me2 levels at the *clr4*^*+*^ coding region, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments. (**E**) qRT-PCR analysis of *clr4*^*+*^ mRNA levels, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.015](10.7554/eLife.06179.015)10.7554/eLife.06179.016Figure 6---figure supplement 1.The effect of *clr4-R406H* on silencing of *otr::ura4^+^*.Right, qRT-PCR analysis of *ura4*^*+*^ RNA levels, normalized against *act1*^*+*^. Error bars represent standard deviation of three experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.016](10.7554/eLife.06179.016)

Discussion {#s3}
==========

The formation of heterochromatin and its subsequent spreading result in silencing of large chromosomal domains in a sequence-independent manner. Therefore, the sites of heterochromatin assembly and the extent of heterochromatin spreading are generally precisely controlled to maintain stable gene expression patterns. In addition to the diverse pathways that accurately initiate heterochromatin assembly, anti-silencing activities also play essential roles in limiting heterochromatin spreading to shape the chromatin landscape.

Our results reveal a novel function of the Mst2 complex in regulating histone turnover at heterochromatin regions to counteract heterochromatin spreading. Loss of Mst2 bypasses the requirement of RNAi for pericentric heterochromatin assembly ([@bib39]), increases heterochromatin spreading and silencing at telomeres ([Figure 1](#fig1){ref-type="fig"}) ([@bib10]), and increases the efficiency of ectopic heterochromatin assembly ([@bib37]), which is phenotypically very similar to *epe1∆*. Biochemically, the Mst2 complex is a highly specific histone H3K14 acetyltransferase and mutations resulting in the loss of its enzymatic activity, such as *mst2-E274Q* or *nto1∆* ([@bib53]), also resulted in slow growth when combined with *epe1∆*, suggesting that its enzymatic activity is required for counteracting silencing. *H3K14* mutants have a direct effect on heterochromatin assembly independent of its acetylation state, making it difficult to directly address whether H3K14 is the only target of Mst2 in regulating heterochromatin spreading ([@bib30]; [@bib39]; [@bib2]). Therefore, it remains possible that Mst2 modifies heterochromatin assembly factors to regulate histone turnover and counteract silencing.

Our results also revealed the functional redundancy of Mst2 and Epe1 in regulating heterochromatin spreading, which explains why heterochromatin spreading only occurs in a small population of cells and requires the overexpression of Swi6 to be efficiently detected ([@bib35]; [@bib52]). In the absence of both Mst2 and Epe1, heterochromatin spreading increases significantly, leading to the inactivation of essential genes and severe growth defects. Such strong survival pressure results in the selection of cells that can establish heterochromatin at the *clr4*^*+*^ locus, leading to reduced transcription of *clr4*^*+*^ and decreased Clr4 protein levels, thus allowing cells to reach a new equilibrium where heterochromatin assembly at regular locations is intact while the negative effects of heterochromatin spreading are mitigated ([Figure 7](#fig7){ref-type="fig"}). Although we cannot test the epigenetic profiles of individual cells, it is possible that *mst2Δ epe1Δ* cells initially generate varied epigenetic profiles, and only cells containing H3K9me at the *meu6-clr4* locus are clonally selected due to its beneficial effects on cell growth. The quick generation of this epigenetic suppressor also benefited from the stabilization of ectopic heterochromatin domains in *mst2∆ epe1∆* cells. Once established, such ectopic heterochromatin can be inherited, but can also be quickly erased to allow cells to adapt to new conditions. Interestingly, when H3K9me at the *clr4*^*+*^ locus is blocked, the survival pressure instead selects cells that can establish heterochromatin at the *rik1*^*+*^ locus to similarly reduce heterochromatin-forming abilities. The flexibility in heterochromatin assembly allows cells and their subsequent generations to efficiently cope with changes in heterochromatin levels.10.7554/eLife.06179.017Figure 7.A model of the negative feedback of heterochromatin assembly.**DOI:** [http://dx.doi.org/10.7554/eLife.06179.017](10.7554/eLife.06179.017)

The formation of heterochromatin at the *clr4*^*+*^ locus does not employ any of the known heterochromatin assembly pathways. The intact 3'-UTR region of *clr4*^*+*^ seems to initiate heterochromatin through a novel mechanism, although such a mechanism must be very inefficient in wild-type cells given that no H3K9me is observed. It is interesting to note that the 3′-UTR of *clr4*^*+*^ overlaps the entire *meu6*^*+*^ gene, which is arranged in a convergent orientation. The expression of *meu6*^*+*^ is extremely low during vegetative growth, but is upregulated during meiosis, which might interfere with Clr4 expression, resulting in the loss of heterochromatin islands as seen in cells under conditions that induce meiosis ([@bib58]).

It has long been known that heterochromatin assembly in fission yeast is tightly regulated to prevent promiscuous heterochromatin assembly. For example, the amount of heterochromatin proteins such as Swi6 is limiting, and ectopic heterochromatin assembly can only succeed when Swi6 is overexpressed or when endogenous heterochromatin structures are compromised to release silencing proteins ([@bib20]; [@bib23]; [@bib45]). Moreover, sub-telomeric heterochromatin regions, which contain no boundaries and no essential genes, can serve as 'sinks' to absorb extra heterochromatin proteins ([@bib45]). These extensive pathways that limit heterochromatin assembly might be a response to the high enzymatic activity of Clr4, which is likely required for heterochromatin assembly in an otherwise highly compact and active genome. Our results provide an additional layer of control for cells to monitor heterochromatin levels through a negative feedback mechanism that uses the potentially promiscuous nature of heterochromatin assembly to induce heterochromatin formation at genes encoding heterochromatin assembly factors, thus ensuring the epigenetic stability of the genome.

Our results fit into a growing body of evidence demonstrating that epigenetic regulation of gene expression enables cells to adopt a wide variety of phenotypes to adapt to external or internal stresses ([@bib16]). Compared to genetic mutations, epigenetic mutations provide much faster responses. Most importantly, the effects are reversible, allowing easy reversion to normal epigenetic profiles when external stimuli disappear. In cancer cells, such epigenetic variations might result in the inactivation of tumor suppressor genes during tumorigenesis and might also enable tumor cells to survive certain therapies ([@bib43]; [@bib26]). Therefore, our work sheds light on the mechanisms underlying how a relatively stable heterochromatic profile is maintained both under normal conditions and upon heterochromatin stress and will guide future efforts to combat epigenetic adaptations that interfere with cancer treatment.

Materials and methods {#s4}
=====================

Fission yeast strains and genetic analyses {#s4-1}
------------------------------------------

Detailed genotypes of strains used are listed in [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}. Strains containing *meu6∆* or *meu6-Flag* and *urg1-hht2-Flag* were constructed by a PCR-based module method. Genetic crosses were used to construct all other strains. For serial dilution plating assays, ten-fold dilutions of mid-log-phase cultures were plated on the indicated medium and grown for 3 days at 30°C.

Genetic screen of the fission yeast deletion library {#s4-2}
----------------------------------------------------

A two-step cross scheme was employed to avoid the accumulation of suppressors before colony growth measurement. Query strains (*mst2∆::natMX6* and *epe1∆::hphMX6*) were first separately mated with the fission yeast deletion library arrayed in 384 strains/plate format with the aid of the Singer RoToR HDA pinning robot as previously described ([@bib45]). After mating and selection, the resulting haploid double mutant libraries containing individual gene deletions with either *mst2∆* or *epe1∆* were mated again, and haploid triple mutants were selected on YES medium supplemented with antibiotics to measure cell growth.

Chromatin immunoprecipitation (ChIP) analysis {#s4-3}
---------------------------------------------

ChIP analyses with H3K9me2 antibody (Abcam, Cambridge, MA) were performed as described previously ([@bib45]). Quantitative real-time PCR (qPCR) was performed with Maxima SYBR Green qPCR Master Mix (Fermentas, Grand Island, NY) in a StepOne Plus Real-Time PCR System (Applied Biosystems, Grand Island, NY). DNA serial dilutions were used as templates to generate a standard curve of amplification for each pair of primers, and the relative concentration of the target sequence was calculated accordingly. An *act1* fragment was used as reference to calculate the enrichment of ChIP over WCE for each target sequence. Oligos used are listed in [Supplementary file 4](#SD4-data){ref-type="supplementary-material"}.

For histone turnover assay, cells were cultured in EMM--uracil medium, and then arrested for 4 hr by 20 mm HU, followed by the addition of 0.25 mg/ml uracil to induce the expression of H3-Flag, before ChIP analysis was performed.

ChIP--chip analyses were performed according to the 'Agilent Yeast ChIP-on-chip Analysis' protocol. The microarray used was an Agilent *S. pombe* Whole Genome ChIP-on-chip Microarray with additional probes that encompass centromeres, which were originally absent from the array due to the repetitive nature of these DNA sequences. At least two repeats were performed for each microarray experiment. To control for the experimental variation, the average of top 20 probes was set to 1 before averaging the results. For heterochromatin islands, the cutoff of H3K9me2 levels is 0.2. Microarray data have been deposited in the GEO database under accession number GSE60521.

RNA analyses {#s4-4}
------------

Total cellular RNA was isolated from log-phase cells using MasterPure yeast RNA purification kit (Epicentre, Madison, WI) according to the manufacturer\'s protocol. Quantification with qRT-PCR was performed with Power SYBR Green RNA-to-CT one-step Kit (Applied Biosystems). RNA serial dilutions were used as templates to generate the standard curve of amplification for each pair of primers, and the relative concentration of target sequence was calculated accordingly. An *act1* fragment served as reference to normalize the concentration of samples. The concentration of each target gene in wild type was arbitrarily set to 1 and served as references for other samples. Oligos used are listed in [Supplementary file 4](#SD4-data){ref-type="supplementary-material"}.
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Major dataset {#s6-1}
-------------

The following dataset was generated:

Wang J, 2014,Epigenetic adaptation to uncontrolled heterochromatin spreading,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60521>,Publicly available at NCBI Gene Expression Omnibus <http://www.ncbi.nlm.nih.gov/geo/> (GSE60521).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your manuscript titled "Rapid Epigenetic Adaptation to Uncontrolled Heterochromatin Spreading" for consideration for publication at *eLife*. Your manuscript was reviewed by three experts in the field and by a member of the Board of Reviewing Editors (BRE). The detailed reviews for your manuscript are included at the end of this letter. After a full discussion of the study and the reviews, we are happy to report that the reviewers and the BRE member found the study of interest to the journal and therefore we are happy to consider a revised manuscript. As you will see from the reviewers\' comments, there are several minor points to be considered and need to be addressed. Also, the third reviewer has suggested 5 points under his/her major concerns. Upon discussion, we do not require you to address these points for publication, however, if you have data that can clarify the reviewers concerns, we suggest including such new data in the revised manuscript.

*Reviewer \#1*:

In this study Wang et al. describe a role for the conserved Mst2 histone acetyltransferase in regulation of heterochromatin spreading and inhibition of ectopic heterochromatin in fission yeast. In addition, they discover that the combined loss of Mst2 and Epe1 results in uncontrolled heterochromatin spreading and the formation of ectopic heterochromatin leading to inactivation of essential genes. Most importantly, their results reveal an epigenetic adaptation mechanism that can lead to the inactivation of heterochromatic genes such as *clr4* and *rik1* in *mst2 epe1* double mutant cells that allows these cells to survive.

This is an exciting and important study that provides insight into the role of anti-silencing modifications in control of heterochromatin spreading. The results on adaptation of cells to loss of Mst2 and Epe1 are particularly interesting and reveal epigenetic, rather than genetic, inactivation as a major survival strategy in response to inappropriate heterochromatin spreading. This may be particularly relevant to cancer and other diseases linked to changes in chromatin modifications. The results raise many interesting questions that will stimulate new lines of study and will be of great interest to the field. The main conclusions of the paper are supported by a series of straightforward and beautifully executed experiments. I am happy to support publication in *eLife*.

Minor comment:

In the subsection headed "Mst2 and Epe1 are required to counteract the high activity of Clr4", the authors state: "these cells are able to efficiently silence an *otr::ura4*^+^ reporter gene." No data is shown to support this claim and should probably be added to the supplemental section.

*Reviewer \#2*:

Wang et al. described a new role of the fission yeast Mst2 protein, a subunit of a HAT complex in the regulation of histone turnover at the heterochromatin regions, heterochromatin spreading and ectopic heterochromatin assembly. Deletion of mst2+ resulted not only in increased of heterochromatin spreading and silencing near telomeres but also increased ectopic heterochromatin assembly. Interestingly, the loss of Mst2 has similar phenotype in heterochromatin assembly as the loss of the anti-silencing factor Epe1. Further analysis revealed that the combined loss of Mst2 and Epe1 anti-silencing factors leads to widespread H3K9mehtyulation and growth defects due to gene inactivation. Surprisingly, the *mst2Δ epe1Δ* cells recover by accumulation of heterochromatin at genes required for heterochromatin assembly particularly clr4^+^.

My main concern is that the suppression of the *mst2∆ epe1∆* phenotype via silencing of clr4^+^ is a phenomenon that, while interesting and cool, is entirely specific to a mutant situation. Presumably, this never occurs in wild-type cells. In that sense, this paper is more about investigating a mutant pathology than revealing how wild-type cells function.

Minor points:

1\) The authors state that the constitutive domains at the centromeres in mst2Δ are in good agreement with the wild type. This statement is only true for the chromosome 1. According to the [Figure 1D](#fig1){ref-type="fig"}, we can clearly observe a decrease of the H3K9me signal at the centromere 2 and 3 in *mst2Δ* compare to the wild type. How can the authors explain these discrepancies?

2\) The authors\' *epe1Δ* is at odds with those of Zofall ([@bib58]) who reported subtelomeric spread in *epe1Δ* cell.

3\) How do the authors explain that only few heterochromatics islands can show a spread of H3K9me in the triple mutants *mst2Δ epe1Δ swi6Δ*?

4\) Is RNAi required for ectopic silencing establishment?

5\) In the Introduction, the authors should indicate that the establishment of constitutive heterochromatin at repetitive DNA elements requires RNA interference at the centromeres but not at other element such as telomeres ([@bib37]).

6\) The authors do not mention the recruitment of RNAi to these specific meiotic genes by the Mmi RNA surveillance machinery ([@bib17]).

7\) The authors state that they identified a few heterochromatic islands with a low level of H3K9me. This analysis should be explained more clearly in the Methods.

8\) For a better understanding, the authors should add on the x axis the title "Chromosome position" on the ChIP-chip figures.

9\) In the subsection headed "Misregulation of heterochromatin affects the fitness of *mst2∆ epe1∆* cells", the two mutants *mst2Δ* and *epe1Δ* appear to have a very different phenotype on telomeres ([Figure 1E](#fig1){ref-type="fig"}).

10\) [Figure 2A](#fig2){ref-type="fig"}, how many days of colony growth?

11\) [Figure 2B](#fig2){ref-type="fig"}, the time of growth is not described.

12\) [Figure 2G](#fig2){ref-type="fig"}, how did the RNAi factors score in this screen?

13\) At the end of the subsection headed "Increased heterochromatin spreading is responsible for the initial growth defects of *mst2∆ epe1∆* cells", add *clr4*^*+*^ locus.

14\) [Figure 4D](#fig4){ref-type="fig"}, *mst2Δ Flag-clr4*^*+*^ is missing.

*Reviewer \#3*:

This manuscript describes the unrestrained assembly of heterochromatin via H3K9 methylation in fission yeast devoid of the H3K14 acetyltransferase Mst2 and the putative histone/protein demethylase Epe1. Epe1 may be an H3K9 demethylase and H3K14 acetylation is linked with transcription and histone turnover. Both activities act in parallel pathways to limit the extent of heterochromatin domains.

Interestingly, *mst2 epe1* double null cells are initially very slow growing but suppressors rapidly arise allowing normal growth. They show that natural suppressors result in silencing of the gene encoding the Clr4 H3K9 methyltransferase due to the formation of heterochromatin over the *clr4* gene itself. The *rik1* gene (a component of Clr4 methyltransferase complex) is similarly silenced in *mst2 epe1* mutant cells when clr4 cannot be silenced. Although the mechanism of silencing of the clr4 gene (and *rik1* gene) is not known, alteration of the region flanking the 3\' end of the *clr4* gene inhibits heterochromatin assembly. Overall the results are interesting, however more specific information regarding how *meu6-clr4* locus is actually silenced would strengthen the manuscript.

Issues to be addressed:

1\) The histone turnover experiment ([Figure 1](#fig1){ref-type="fig"}) would benefit from the inclusion of total H3 control ChIP in WT and mutant backgrounds. Also, since histone turnover is known to be much greater on highly transcribed genes such as *act1*, it would be wise to also compare turnover levels at *dh* to repressed genes (e.g. *nmt1* or other) where histone turnover should be low and thus provide a more accurate comparison. This would also provide an internal control to confirm that differences in histone turnover levels at different loci are being detected (i.e. *act1* v *nmt1*).

2\) What is the frequency of fast growing colonies with *clr4*^*+*^ epialleles (and *rik1*^*+*^ epialleles) as opposed to the frequency of genuine mutations that inactivate clr4 or genes encoding other heterochromatin components?

3\) Quantitative PCR ChIP, RT-PCR, ChIP-chip: It is not immediately clear from figures how ChIP signals were quantified and what is presented. My assumption was that it is %IP shown. Only when I read the methods/legends did I discover that all values are normalized relative to the *act1* gene. For ChIP the Y axis in all figures should be clearly labelled H3-FLAG/H3K9me2/ at *dg/clr4/rik1* relative to *act1* (or H3K9me2 ratio *dg/act1* etc.). Likewise, *clr4/rik1* transcript/mRNA relative to act1 in all relevant figures.

For ChIP-chip analyses, details should be provided for how H3K9me2 profiles were obtained and the methods utilized should conform with normally accepted practices for microarray data processing and presentation. From [Figure 1 to 3](#fig1 fig2 fig3){ref-type="fig"}, it looks as if all values may be plotted relative to a control locus? The processing employed and units used need to be clearly described and indicated.

4\) The data in [Figure 5](#fig5){ref-type="fig"} is discussed in a section entitled: "The mechanism of heterochromatin assembly at the clr4^+^ locus". Here the authors just show that manipulation of sequences flanking the 3\' end of the *clr4* gene prevents heterochromatin assembly over *clr4* in *mst1 epe1* double null cells. They find that *dcr1*/RNAi, Mmi1/exosome and Pab2/3\' end processing pathways are not involved. Red1 should be also tested as it is more directly involved in the recruitment of Clr4 to some heterochromatin islands. It would also make sense to test Rrp6 and Mtl1.

No explanation is given for how they conclude from RNA-seq data ([Figure 5A](#fig5){ref-type="fig"}) that the *clr4* transcript runs through the convergent *meu6* gene. Is the same sized transcript detected by northern with *meu6* and *clr4* probes? Is 5\' RACE consistent with a *clr4* (sense)-*meu6* (antisense) RNA being synthesized? Regardless, the experiments presented do not actually reveal the mechanism of heterochromatin assembly at the *clr4* locus in *mst2 epe1* null cells. How does this 3\' region nucleate heterochromatin? If it is something to do with the 3\' UTR of the *clr4* RNA then a more precise insertion of a known transcription terminator downstream of the Clr4 ORF should prevent heterochromatin assembly.

Does the *clr4* locus have anything in common with the rik1 locus and other H3K9me2 islands detected in *mst1 epe1 swi6* null cells? Apart from *meu6-clr4*, are there other H3K9me2 islands specific to *mst1 epe1 swi6* null cells that might be informative with respect to mechanism?

Related to this, did the screen of the deletion library ([Figure 2D](#fig2){ref-type="fig"}) identify any additional genes that suppress the *mst2 epe1* slow growth phenotype but do not correspond to known heterochromatin components? If so, presumably they might suggest how *meu6-clr4* is silenced and these should at least be discussed.

5\) More extensive analysis is required to allow the authors to conclude that *clr4-R406H* "mildly affected silencing" and that "these cells are able to efficiently silence the *otr::ura4*^*+*^ reporter". A simple 5-FOA plate, with no -ura4 plate for comparison, is not sufficient. Are H3K9me2 levels of *dg/dh* repeats reduced? Are *dg/dh* transcript levels increased?

10.7554/eLife.06179.023

Author response

Reviewer \#1:

*In the subsection headed "Mst2 and Epe1 are required to counteract the high activity of Clr4", the authors state:* "*these cells are able to efficiently silence an* otr::ura4^+^ *reporter gene.*" *No data is shown to support this claim and should probably be added to the supplemental section*.

We have removed this claim.

Reviewer \#2:

*My main concern is that the suppression of the* mst2 ∆epe1∆ *phenotype via silencing of* clr4^+^ *is a phenomenon that, while interesting and cool, is entirely specific to a mutant situation. Presumably, this never occurs in wild-type cells. In that sense, this paper is more about investigating a mutant pathology than revealing how wild-type cells function*.

Although the generation of an epigenetically silenced *clr4*^*+*^ allele only happens in *mst2∆ epe1∆* background, we can extrapolate that any other mutations or environmental insults resulting in a massive increase in heterochromatin assembly can trigger a similar response. Moreover, our results demonstrate the functional redundancy of Mst2 and Epe1 in controlling heterochromatin assembly in wild type cells.

*Minor points*:

*1) The authors state that the constitutive domains at the centromeres in mst2Δ are in good agreement with the wild type. This statement is only true for the chromosome 1. According to the* [*Figure 1D*](#fig1){ref-type="fig"}*, we can clearly observe a decrease of the H3K9me signal at the centromere 2 and 3 in* mst2Δ *compare to the wild type. How can the authors explain these discrepancies*?

We have included detailed microarray data around centromere 2 and 3 in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}. The apparent higher amount of H3K9me2 at these regions in wild type cells was due to higher values of only a few probes. For the majority of probes, the values are very similar between wild type and *mst2∆* cells. We also used thinner lines in [Figure 1D](#fig1){ref-type="fig"} to better visualize this effect.

*2) The authors\'* epe1Δ *is at odds with those of Zofall (*[@bib58]*) who reported subtelomeric spread in* epe1Δ *cell*.

We have included detailed microarray data of the four telomeric regions of chromosome I and II ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}). In all cases, the effect of *epe1∆* on telomeric heterochromatin is very minor. We currently do not know the reason for the discrepancy with [@bib58]. It is known that *epe1∆* shows variable phenotypes in centromere silencing ([@bib48]), suggesting that there might be two different sub-populations of cells with different behaviours. We have added a description of this discrepancy in the text (in the second paragraph of the subsection headed "Mst2 regulates histone turnover at heterochromatin").

*3) How do the authors explain that only few heterochromatics islands can show a spread of H3K9me in the triple mutants* mst2Δ epe1Δ swi6Δ?

We observed spreading of H3K9me at the majority of heterochromatic islands in *mst2∆ epe1∆ swi6∆* cells. Due to space limitations, we only showed one in the original version. We have now included detailed data of all heterochromatin islands in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}.

*4) Is RNAi required for ectopic silencing establishment*?

We found that RNAi is not required for ectopic silencing establishment at the *clr4*^*+*^ locus. We crossed *mst2∆ dcr1∆* with *epe1∆ dcr1∆* and found that all *mst2∆ epe1∆ dcr1∆* cells can still recover, consistent with our ChIP analysis that there is H3K9me at the *clr4*^*+*^ locus in these cells ([Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}).

*5) In the Introduction, the authors should indicate that the establishment of constitutive heterochromatin at repetitive DNA elements requires RNA interference at the centromeres but not at other element such as telomeres (*[@bib37]*)*.

We disagree with the reviewer\'s statement. It has been shown that the DNA repeats at telomeres contribute to heterochromatin establishment ([@bib24]). The ability to establish heterochromatin at telomeres in RNAi mutant, as described in [@bib37], is because of redundant heterochromatin establishment pathways at telomeres ([@bib24]).

*6) The authors do not mention the recruitment of RNAi to these specific meiotic genes by the Mmi RNA surveillance machinery (*[@bib17]*)*.

We added a sentence in the fourth paragraph of the Introduction to describe the recruitment of RNAi to meiotic genes.

*7) The authors state that they identified a few heterochromatic islands with a low level of H3K9me. This analysis should be explained more clearly in the Methods*.

We stated in the Methods section the specific cut off used to determine heterochromatin islands. A list of the heterochromatin islands was included in [Supplementary File 1](#SD1-data){ref-type="supplementary-material"}.

*8) For a better understanding, the authors should add on the x axis the title* "*Chromosome position*" *on the ChIP-chip figures*.

We added axis label "Chromosome position" for all ChIP-chip figures.

*9) In the subsection headed "Misregulation of heterochromatin affects the fitness of* mst2∆ epe1∆ *cells", the two mutants* mst2Δ *and* epe1Δ *appear to have a very different phenotype on telomeres (*[*Figure 1E*](#fig1){ref-type="fig"}*)*.

Even though *mst2∆* and *epe1∆* have similar effects on histone turnover, ectopic heterochromatin assembly ([Figure 1](#fig1){ref-type="fig"}), and on suppression of RNAi mutants ([@bib39] and [@bib48]), they behaved differently in the spreading of heterochromatin domains at telomeres and centromeres ([Figure 1](#fig1){ref-type="fig"}), as well as heterochromatin maintenance in the absence of initiation signals ([@bib37]), suggesting that these two mutants are not identical.

*10)* [*Figure 2A*](#fig2){ref-type="fig"}*, how many days of colony growth*?

The picture shown in [Figure 2A](#fig2){ref-type="fig"} is 6 days of growth after dissection of tetrads. We added the description in the figure legend.

*11)* [*Figure 2B*](#fig2){ref-type="fig"}*, the time of growth is not described*.

The dilution analyses were performed after 1 day of growth in rich medium. We added the description in the figure legend.

*12)* [*Figure 2G*](#fig2){ref-type="fig"}*, how did the RNAi factors score in this screen*?

RNAi factors were not identified in our screen. We added a description of this fact in the text (in the subsection headed "Misregulation of heterochromatin affects the fitness of *mst2∆ epe1∆* cells"). We also showed a tetrad dissection of an *mst2∆ dcr1∆* and *epe1∆ dcr1∆* cross in [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}.

*13) At the end of the subsection headed "Increased heterochromatin spreading is responsible for the initial growth defects of* mst2∆ epe1∆ *cells", add* clr4^+^ *locus*.

We changed the text to "*mei4*^*+*^ and *clr4*^*+*^ loci".

*14)* [*Figure 4D*](#fig4){ref-type="fig"}*,* mst2Δ Flag-clr4^+^ *is missing.*

We added a panel in [Figure 4D](#fig4){ref-type="fig"} to show different combinations. There are no growth defects associated with *mst2∆ Flag-clr4*.

Reviewer \#3:

*1) The histone turnover experiment (*[*Figure 1*](#fig1){ref-type="fig"}*) would benefit from the inclusion of total H3 control ChIP in WT and mutant backgrounds. Also, since histone turnover is known to be much greater on highly transcribed genes such as* act1*, it would be wise to also compare turnover levels at* dh *to repressed genes (e.g.* nmt1 *or other) where histone turnover should be low and thus provide a more accurate comparison. This would also provide an internal control to confirm that differences in histone turnover levels at different loci are being detected (i.e.* act1 *v* nmt1*)*.

We normalized our data to a non-transcribed mating-type region, which showed low histone turnover ([@bib3]), in new [Figure 1C](#fig1){ref-type="fig"}. The results are similar to those without such normalization.

*2) What is the frequency of fast growing colonies with* clr4^+^ *epialleles (and* rik1^+^ *epialleles) as opposed to the frequency of genuine mutations that inactivate* clr4 *or genes encoding other heterochromatin components*?

Our data suggest that the *clr4*^*+*^ epiallele is much more prevalent than genuine genetic mutations. For example, experiments in [Figure 4](#fig4){ref-type="fig"} showed that the suppressor is epigenetic rather than genetic, as cells inherited the silenced *clr4*^*+*^ epiallele can revert back to normal. The results shown are representative of multiple independent suppressor strains. The accurate determination of the frequency of epiallele vs. genuine mutations requires genome sequencing of independent suppressor strains.

*3) Quantitative PCR ChIP, RT-PCR, ChIP-chip: It is not immediately clear from figures how ChIP signals were quantified and what is presented. My assumption was that it is %IP shown. Only when I read the methods/legends did I discover that all values are normalized relative to the* act1 *gene. For ChIP the Y axis in all figures should be clearly labelled H3-FLAG/H3K9me2/* at dg/clr4/rik1 *relative to* act1 *(or H3K9me2 ratio* dg/act1 *etc). Likewise,* clr4/rik1 *transcript/mRNA relative to* act1 *in all relevant figures*.

*For ChIP-chip analyses, details should be provided for how H3K9me2 profiles were obtained and the methods utilized should conform with normally accepted practices for microarray data processing and presentation. From* [*Figure 1 to 3*](#fig1 fig2 fig3){ref-type="fig"}*, it looks as if all values may be plotted relative to a control locus? The processing employed and units used need to be clearly described and indicated*.

We added labels in all relevant figures when a control locus was employed for normalization. For ChIP-chip analysis, we normalized data in order to average results from different experiments. We explained in the Methods section about the details of data processing.

*4) The data in* [*Figure 5*](#fig5){ref-type="fig"} *is discussed in a section entitled:* "*The mechanism of heterochromatin assembly at the* clr4^+^ *locus*"*. Here the authors just show that manipulation of sequences flanking the 3\' end of the* clr4 *gene prevents heterochromatin assembly over* clr4 *in* mst1 epe1 *double null cells. They find that* dcr1*/RNAi, Mmi1/exosome and Pab2/3\' end processing pathways are not involved. Red1 should be also tested as it is more directly involved in the recruitment of Clr4 to some heterochromatin islands. It would also make sense to test Rrp6 and Mtl1*.

We changed the section title to: "Sequence 3' to *clr4*^*+*^ is required for heterochromatin assembly at the *clr4*^*+*^ locus in *mst2∆ epe1∆* cells". We attempted to generate triple mutations of *mst2∆ epe1∆ red1∆* and *mst2∆ epe1∆ red1∆ rrp6∆.* However, we were unable to generate such strains. Both *red1∆* and *rrp6∆* cells are extremely sick, making it difficult to determine whether the lethality is due to the cumulative sickness of these strains or because such strains cannot generate clr4^+^ epialleles. *Mtl1* is an essential gene, and we currently do not have *mtl1* mutant.

*No explanation is given for how they conclude from RNA-seq data (*[*Figure 5A*](#fig5){ref-type="fig"}*) that the* clr4 *transcript runs through the convergent* meu6 *gene. Is the same sized transcript detected by northern with* meu6 *and* clr4 *probes? Is 5\' RACE consistent with a* clr4 *(sense)-*meu6 *(antisense) RNA being synthesized? Regardless, the experiments presented do not actually reveal the mechanism of heterochromatin assembly at the* clr4 *locus in* mst2 epe1 *null cells. How does this 3\' region nucleate heterochromatin? If it is something to do with the 3\' UTR of the* clr4 *RNA then a more precise insertion of a known transcription terminator downstream of the Clr4 ORF should prevent heterochromatin assembly*.

*Does the* clr4 *locus have anything in common with the rik1 locus and other H3K9me2 islands detected in* mst1 epe1 swi6 *null cells? Apart from* meu6-clr4*, are there other H3K9me2 islands specific to* mst1 epe1 swi6 *null cells that might be informative with respect to mechanism*?

Our RNA-seq data is strand specific, which clearly indicated that the *clr4*^*+*^ transcript covers the *meu6*^*+*^ coding sequence and that the *meu6*^*+*^ mRNA levels are very low. Such a conclusion is consistent with the annotation of genome in Pombase based on results of Marguerate et al., 2012 and Rhind et al., 2011. Therefore, we believe a 5\'-RACE experiment is unnecessary.

We currently do not know the mechanism that induces heterochromatin assembly at the *clr4*^*+*^ locus, except that sequences 3\' to *clr4*^*+*^ is required for heterochromatin assembly. But we did rule out most of the known heterochromatin establishment mechanisms, such as RNAi, Mmi1, and convergent transcription, indicating that a novel mechanism is involved. We are actively dissecting the mechanisms that establish this ectopic heterochromatin, including precisely manipulating transcription termination at the *clr4*^*+*^ locus, and we believe such an experiment is out of the scope of the current study.

We found that a common theme of the *clr4*^*+*^ and *rik1*^*+*^ loci is that both are adjacent to genes up-regulated during meiosis, although whether there is any causal relationship is still unknown. Apart from *meu6-clr4*, there are other H3K9me2 islands in *mst2∆ epe1∆ swi6∆* cells, such as *mug8*, *SPAC8c9.04*, and *sol1*. However, *meu6-clr4* does not show accumulation of H3K9me in *mst2∆ epe1∆ swi6∆* cells. Therefore, they are not likely to be formed through similar mechanisms.

*Related to this, did the screen of the deletion library (*[*Figure 2D*](#fig2){ref-type="fig"}*) identify any additional genes that suppress the* mst2 epe1 *slow growth phenotype but do not correspond to known heterochromatin components? If so, presumably they might suggest how* meu6-clr4 *is silenced and these should at least be discussed*.

There are a number of additional mutants identified, which are listed in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. Due to the fast generation of the *clr4*^*+*^ epiallele, such an experiment is intrinsically noisy and many of the identified factors are simply noise. The screen is not designed to identify factors required for heterochromatin assembly at the *clr4*^*+*^ locus. Theoretically, such a mutation will result in cells that cannot recover, which can be tested by repeated pinning of the cells to measure their growth. However, there are many strains in the library causing growth defects, and the linkage of genes to three different loci will result in many SGA spots showing growth defects, thus the noise will be too high for such experiments to be informative.

*5) More extensive analysis is required to allow the authors to conclude that* clr4-R406H "*mildly affected silencing*" *and that* "*these cells are able to efficiently silence the* otr::ura4^+^ *reporter*"*. A simple 5-FOA plate, with no -ura4 plate for comparison, is not sufficient. Are H3K9me2 levels of* dg/dh *repeats reduced? Are* dg/dh *transcript levels increased*?

We have removed this claim. We have included RT-PCR analysis of *otr::ura4*^*+*^ transcript levels, shown in [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}.
